A selection visit was successfully completed to participate in a simple, blind, randomized, parallel-group study comparing the efficacy, safety, immunogenicity, and pharmacodynamics of Stelara® iStileukin® drugs at the supportive stage of treatment for moderate to severe ulcerative colitis (UC) with ineffectiveness/loss of clinical response/intolerance to previous treatment, sponsored by GENERIUM JSC.", Russia
The approval of the Ministry of Health Research Center GNR068-UC04 has been received.
- Super User
- Trials
- Read Time: 1 min
- Hits: 0
Our partners
